South Asia (IDA & IBRD) vs Tonga: Immunization, measles
South Asia (IDA & IBRD)
96.9%
in 2024
Tonga
99.0%
in 2024
South Asia (IDA & IBRD) rank
1st
Tonga rank
1st
Immunization, measles over time
- South Asia (IDA & IBRD)
- Tonga
How they compare
Tonga currently reports 99.0% against 96.9% in South Asia (IDA & IBRD), a difference of 2.1%.
Across all 44 years both countries report, Tonga has been ahead every year.
South Asia (IDA & IBRD) ranks 1st and Tonga ranks 1st of 47 groups.
Tonga has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | South Asia (IDA & IBRD) | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 12.3% | 59.3% | 47.0% | Tonga |
| 1990s | 59.8% | 91.5% | 31.7% | Tonga |
| 2000s | 67.7% | 97.1% | 29.4% | Tonga |
| 2010s | 87.9% | 98.5% | 10.6% | Tonga |
| 2020s | 93.1% | 99.0% | 5.9% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, South Asia (IDA & IBRD) or Tonga?
- Tonga, at 99.0% against 96.9% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, measles between South Asia (IDA & IBRD) and Tonga?
- 2.1%, with Tonga ahead.
- How many years of comparable data are there for South Asia (IDA & IBRD) and Tonga?
- 44 years are reported by both, from 1981 to 2024.
- How do South Asia (IDA & IBRD) and Tonga rank globally for immunization, measles?
- South Asia (IDA & IBRD) ranks 1st and Tonga ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.